MED1 is a well-known hypoxia-sensitive transcriptional coactivator and has been extensively studied in various diseases, such as atherosclerosis, pulmonary hypertension, breast cancer, etc. It binds to transcription factors and RNA polymerase II to exert biological effects [10–12]. The gene discussed is MED1; the disease is pulmonary arterial hypertension.